This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Hereditary Multiple Exostoses
Information about Hereditary Multiple Exostoses: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Hereditary Multiple Exostoses
Most recent studies have shown that Hereditary Multiple Exostoses shares some biological mechanisms with bone-diseases, bone-neoplasms, cartilaginous-exostosis, chondroma, chondrosarcoma, compression-of-spinal-cord, congenital-abnormality, dwarfism, dysplasia, exostoses, langer-giedion-syndrome, malignant-neoplasms, malignant-paraganglionic-neoplasm, neoplasms, osteochondrodysplasias, osteochondromatosis, pain.
Among the many pathways, these few ones have gauged particular interests from scientists studying Hereditary Multiple Exostoses, and have been seen in publications frequently: Bone Development, Brain Development, Cell Adhesion, Cell Cycle, Cell Proliferation, Chondrocyte Differentiation, Chondrocyte Proliferation, Cytokinesis, Endochondral Ossification, Gastrulation, Glycosylation, Localization, Metaphase, Ossification, Pathogenesis, Secretion, Secretory Pathway, Sulfation, Translation, Transport
Quite a number of genes have been found to play important roles in Hereditary Multiple Exostoses, such as COL2A1, EXT1, EXT2, EXTL1, EXTL2, EXTL3, FGFR3, HNRNPC, IHH, MAP3K14, MMP12, MTSS1, PTH, PTHLH, PTRH1, SDC2, SLC26A2. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.